| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.0028 | 0.9 |